Cantor Fitzgerald initiated coverage of Invivyd (IVVD) with an Overweight rating and $10 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVVD:
- Invivyd files $350M mixed securities shelf
- Invivyd Appoints New Director Amid Nasdaq Compliance
- Invivyd appoints Wave Life Sciences CEO Paul Bolno to board
- Invivyd announces appointment of Kuhl as Chief Communications Officer
- Invivyd’s Strategic Growth and Diversification: Analyst Recommends Buy Rating